AnalystsAnanda GhoshAnanda Ghosh's Stock Forecasts
AnalystsAnanda Ghosh
Sectors:
Industries:
Analyst Ranking
Top 22%
#1137 out of 5150 analysts
Average Return
+41%
Win Rate
60%9 out of 15
Risk vs Reward
Poor
Good
Ananda Ghosh's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Structure Therapeutics IncGPCR | +313.95% | $16.20 | $67.06 | 2025-08-06 - 2025-12-12 | Buy |
Maze Therapeutics IncMAZE | +120.29% | $17.64 | $38.86 | 2025-07-22 - 2025-12-12 | Buy |
Annexon IncANNX | +103.69% | $2.44 | $4.97 | 2025-08-14 - 2025-12-12 | Buy |
Maze Therapeutics IncMAZE | +66.82% | $23.30 | $38.86 | 2025-09-11 - 2025-12-12 | Buy |
Maze Therapeutics IncMAZE | +65.50% | $23.48 | $38.86 | 2025-09-17 - 2025-12-12 | Buy |
Ananda Ghosh Analyst Color
Get additional color on Ananda Ghosh's coverage of popular stocks
Ananda Ghosh's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Dyne Therapeutics IncDYN | 2 | Buy | $60.00 | +211.36% | Maintains | 7 days ago |
Maze Therapeutics IncMAZE | 4 | Buy | $60.00 | +54.40% | Maintains | 12 days ago |
Pepgen IncPEPG | 3 | Buy | $20.00 | +253.36% | Maintains | a month ago |
Avidity Biosciences IncRNA | 2 | Hold | $72.00 | +0.24% | Downgrades | 2 months ago |
Inventiva SaIVA | 2 | Buy | $24.00 | +438.12% | Maintains | 2 months ago |
Skye Bioscience IncSKYE | 1 | Buy | $20.00 | +1,734.86% | Initiates Coverage On | 3 months ago |
Annexon IncANNX | 1 | Buy | $14.00 | +181.69% | Reiterates | 4 months ago |
Structure Therapeutics IncGPCR | 1 | Buy | $60.00 | -10.53% | Maintains | 4 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.